Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
S. Couillard (Sherbrooke, QC, Canada), S. Peterson (Lund, Sweden), T. Bengtsson (Lund, Sweden), M. Van Den Berge (Groningen, Netherlands), D. Price (Singapore, Singapore), R. Beasley (Wellington, New Zealand), M. Sadatsafavi (Vancouver, BC, Canada), C. Janson (Uppsala, Sweden), A. Papi (Ferrara, Italy), L. Belton (Cambridge, United Kingdom), M. Fagerås (Gothenburg, Sweden), H. Müllerová (Cambridge, United Kingdom), I. Pavord (Oxford, United Kingdom)
Source: International Congress 2022 – Chronic airway diseases: from phenotypes to severity
Session: Chronic airway diseases: from phenotypes to severity
Session type: Oral Presentation
Number: 1412
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Couillard (Sherbrooke, QC, Canada), S. Peterson (Lund, Sweden), T. Bengtsson (Lund, Sweden), M. Van Den Berge (Groningen, Netherlands), D. Price (Singapore, Singapore), R. Beasley (Wellington, New Zealand), M. Sadatsafavi (Vancouver, BC, Canada), C. Janson (Uppsala, Sweden), A. Papi (Ferrara, Italy), L. Belton (Cambridge, United Kingdom), M. Fagerås (Gothenburg, Sweden), H. Müllerová (Cambridge, United Kingdom), I. Pavord (Oxford, United Kingdom). Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort. 1412
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|